Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

Mitral Regurgitation I: Introduction

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Progression to Chronic Limb-Threatening Ischemia After Index Revascularization for Claudication.

JAMA surgery·2025

Same author

The My PAD study for patient-reported outcomes for peripheral vascular intervention in the Vascular Quality Initiative.

Journal of vascular surgery·2025

Same author

Management of claudication in older adults and the role of exercise therapy.

Seminars in vascular surgery·2025

Same author

Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: Focused update.

Journal of vascular surgery·2025

Same author

Prescriber implementation of guideline-directed medical therapy remains poor in the peripheral artery disease population.

Journal of vascular surgery·2025

Same author

Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategy.

JVS-vascular insights·2025

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Changes in left ventricular structure and function following renal artery revascularization.

Matthew A Corriere¹, John R Hoyle, Timothy E Craven

¹Department of Vascular and Endovascular Surgery, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1095, USA.

Annals of Vascular Surgery

|July 28, 2009

Summary

This summary is machine-generated.

Renal artery revascularization led to decreased left ventricular mass in patients with renovascular disease. Diastolic function remained largely unchanged, suggesting further study is needed on long-term cardiac effects and survival benefits.

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Related Experiment Videos

Last Updated: Jun 21, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Area of Science:

Cardiovascular Medicine
Nephrology
Interventional Cardiology

Background:

Renovascular disease is linked to left ventricular hypertrophy (LVH) and diastolic dysfunction, increasing mortality.
The impact of renal artery revascularization on cardiac structure and function needs further elucidation.
Existing data primarily relies on retrospective studies.

Purpose of the Study:

To assess changes in cardiac morphology and function after renal artery revascularization.
To characterize ventricular remodeling and diastolic function post-intervention.
To evaluate the clinical significance of these cardiac changes.

Main Methods:

Prospective cohort study of adult patients undergoing renal revascularization.
Baseline and 6-12 month follow-up echocardiograms to assess ejection fraction (EF) and diastolic function.
Paired t-tests and McNemar's tests for statistical analysis of longitudinal changes.

Main Results:

A significant decrease in left ventricular mass index was observed post-revascularization (p=0.018).
No significant change in systolic function (EF) was detected.
Diastolic function remained largely unchanged, with no significant groupwise improvement.

Conclusions:

Renal artery revascularization is associated with regression of left ventricular mass.
Diastolic function was not significantly altered in the short term.
Further research is warranted to determine long-term effects on survival and cardiac function, emphasizing the role of diastolic dysfunction in renovascular disease.